• Home
  • About Us
    • About Us
    • Subscribe
    • Privacy Policy
  • Advertise
    • Advertise On IP Watch
    • Editorial Calendar
  • Videos
  • Links
  • Help

Intellectual Property Watch

Original news and analysis on international IP policy

  • Copyright
  • Patents
  • Trademarks
  • Opinions
  • People News
  • Venues
    • Bilateral/Regional Negotiations
    • ITU/ICANN
    • United Nations – other
    • WHO
    • WIPO
    • WTO/TRIPS
    • Africa
    • Asia/Pacific
    • Europe
    • Latin America/Caribbean
    • North America
  • Themes
    • Access to Knowledge/ Open Innovation & Science
    • Food Security/ Agriculture/ Genetic Resources
    • Finance
    • Health & IP
    • Human Rights
    • Internet Governance/ Digital Economy/ Cyberspace
    • Lobbying
    • Technical Cooperation/ Technology Transfer
  • Health Policy Watch

WHO Antibiotic Resistance Data Shows Worrying Trend; Industry Ready To Help

29/01/2018 by Catherine Saez, Intellectual Property Watch 2 Comments

Today the World Health Organization released its first set of surveillance data on antibiotic resistance. The data shows that resistance to antibiotics is growing among the world’s most common bacteria, in both high- and low-income countries. Industry announced that it is in the process of making its surveillance data available.

Filed Under: IP Policies, Language, Themes, Venues, English, Finance, Lobbying, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer, WHO

Antimicrobial Benchmark For Industry Launched In Davos

23/01/2018 by Catherine Saez, Intellectual Property Watch Leave a Comment

Across the Alps from this week’s World Health Organization Executive Board meeting, the first ever antimicrobial resistance benchmark was launched today at the World Economic Forum annual meeting in Davos.

Filed Under: IP Policies, Language, Themes, Venues, English, Europe, Finance, Health Policy Watch, Innovation/ R&D, Lobbying, Other International Orgs, Patents/Designs/Trade Secrets, Regional Policy, WHO

US Working To Block UN High-Level Panel On Access To Medicines Ideas In Geneva And Capitals

22/01/2018 by William New, Intellectual Property Watch Leave a Comment

The United States, possibly working with like-minded countries, is working to prevent the further spread among international organisations in Geneva of recommendations put forward by the 2016 United Nations High-Level Panel on Access to Medicines, considering them to be ideological driven and dangerous to economic growth. The comments were made by a US official speaking to a recent US industry event in Washington DC involving many of the US intellectual property attachès, at which two attachés from Geneva described latest developments and strategy for the coming year. A key message from attachès to industry: come to Geneva and engage, starting with this week’s Executive Board meeting at the World Health Organization.

Filed Under: IP Policies, Language, Subscribers, Themes, Venues, Development, English, Health & IP, Innovation/ R&D, Lobbying, North America, Patents/Designs/Trade Secrets, Regional Policy, WHO, WIPO, WTO/TRIPS

Moving Landscape In The IP World – Organisations, Industry, Law Firms

19/01/2018 by Catherine Saez, Intellectual Property Watch 1 Comment

The end of 2017 and start of 2018 brought a lot of changes in the global intellectual property arena. The World Health Organization underwent major changes in its leadership following a new head elected in May, UNAIDS has a new deputy executive director, the World Intellectual Property Organization is seeking a new leader of its Global Challenges division, and the Board of the Internet Corporation for Assigned Names and Numbers decided on a number of appointments. The European Patent Office elected a new president, and the industry world also saw its share of changes. The International Federation of Pharmaceutical Manufacturers and Associations welcomed some new faces, and the head of the Federation of the European Sporting Goods Industry is changing. Law firms saw a high level of revolving chair movements, and promotions of attorneys to partners.

Filed Under: Features, People News, IP Policies, Language, Themes, Venues, Copyright Policy, English, Europe, Finance, Health & IP, IP Law, Lobbying, North America, Patents/Designs/Trade Secrets, Regional Policy, Trademarks/Geographical Indications/Domains, United Nations - other, WHO, WIPO

EPO-EU Conference Examines Hot Topic Of Patentability Of Plants In Europe

18/01/2018 by Catherine Saez, Intellectual Property Watch Leave a Comment

The last couple of years have brought heated discussions in Europe on the patentability of plant innovations, leading to a recent amendment of patent application rules at the European Patent Office. Two major actors share this innovation landscape: the biotechnologists and the plant breeders, with similar but not identical needs for protecting their invention. A joint conference on innovation in the plant sector was held recently by the EPO and the Community Plant Variety Office.

Filed Under: Features, IP Policies, Language, Subscribers, Themes, Venues, Biodiversity/Genetic Resources/Biotech, English, Environment, Europe, Human Rights, IP Law, Innovation/ R&D, Lobbying, Patents/Designs/Trade Secrets, Regional Policy, Traditional and Indigenous Knowledge

Industry Alliance Report: Companies Invest In AMR R&D, Need More Pull Incentives

18/01/2018 by Intellectual Property Watch 1 Comment

An alliance of over a hundred industries seeking to curb antimicrobial resistance launched its first report today. According to the report, a number of companies are heavily investing in research and development, and work to improve access to their diagnostic products and preventing therapies.

Filed Under: IP-Watch Briefs, IP Policies, Language, Themes, Venues, English, Europe, Health Policy Watch, Innovation/ R&D, Lobbying, Patents/Designs/Trade Secrets, Regional Policy, WHO

Global Summit On IP And Access Discusses Impact Of TRIPS-Plus Measures On Public Health

17/01/2018 by Catherine Saez, Intellectual Property Watch 10 Comments

A network of civil society organisations chose the birthplace of the World Trade Organization, Marrakesh, to hold a global summit on intellectual property and access to medicines this week. Part of the summit focused on stringent IP measures in free trade agreements in particular with the European Union, introducing patent term extension and data exclusivity periods.

Filed Under: Features, IP Policies, Language, Themes, Venues, Bilateral/Regional Negotiations, Development, English, Health & IP, Human Rights, Innovation/ R&D, Lobbying, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer, United Nations - other, WTO/TRIPS

Heads Of State At Davos’ Door: Trump, Modi, Macron, May

17/01/2018 by Catherine Saez, Intellectual Property Watch 1 Comment

The World Economic Forum is meeting next week in Davos, with Indian Prime Minister Narenda Modi opening the forum, and US President Donald Trump closing it. One of the focuses of the annual meeting will be on finding ways to reaffirm international cooperation on common challenges, such as the environment and the global economy.

Filed Under: IP Policies, Language, Themes, Venues, Copyright Policy, Development, English, Finance, Health Policy Watch, Innovation/ R&D, Lobbying, Other International Orgs, Patents/Designs/Trade Secrets

Libraries – A Trio Of European Court Rulings

16/01/2018 by Intellectual Property Watch Leave a Comment

In recent years, the Court of Justice of the European Union (CJEU), Europe’s highest court, has made three important rulings concerning digital library activities in Europe, Vincent Bonnet and Barbara Stratton write on the EIFL blog.

Filed Under: Features, Inside Views, IP Policies, Language, Themes, Venues, Access to Knowledge/ Education, Copyright Policy, English, Europe, IP Law, Information and Communications Technology/ Broadcasting, Lobbying, Regional Policy

Guide To The WHO Executive Board: Access To Medicines, Noncommunicable Diseases, Non-State Actors

15/01/2018 by Catherine Saez, Intellectual Property Watch Leave a Comment

The World Health Organization Executive Board meets next week. On the agenda are recommendations of a review group on the WHO Global Strategy on Public Health, Innovation and Intellectual Property, and WHO proposed actions to increase access to affordable and safe medicines and diagnosis. The Executive Board is also expected to consider a report on noncommunicable diseases, new possible organisations to enter into official relationships with WHO, and how to address the global burden of snakebites, including access to treatment.

Filed Under: Features, IP Policies, Language, Subscribers, Themes, Venues, Development, English, Finance, Health & IP, Innovation/ R&D, Lobbying, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer, United Nations - other, WHO

  • « Previous Page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 101
  • Next Page »
  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • Vimeo
My Tweets

IPW News Briefs

Saudis Seek Alternative Energy Partners Through WIPO Green Program

Chinese IP Officials Complete Study Of UK, European IP Law

Perspectives on the US

In US, No Remedies For Growing IP Infringements

US IP Law – Big Developments On The Horizon In 2019

More perspectives on the US...

Supported Series: Civil Society And TRIPS Flexibilities

Civil Society And TRIPS Flexibilities Series – Translations Now Available

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa

Read the TRIPS flexibilities series...

Paid Content

Interview With Peter Vanderheyden, CEO Of Article One Partners

More paid content...

IP Delegates in Geneva

  • IP Delegates in Geneva
  • Guide to Geneva-based Public Health and IP Organisations

All Story Categories

Other Languages

  • Français
  • Español
  • 中文
  • اللغة العربية

Archives

  • Archives
  • Monthly Reporter

Staff Access

  • Writers

Sign up for free news alerts

This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy

Copyright © 2025 · Global Policy Reporting